Zenas Biopharma, Inc.: Citigroup raises target price to $48 from $41
ZBIO•Citigroup raised its target price for Zenas Biopharma to $48 from $41.
Related News
Flutter discloses incoming CEO Dan Taylor pay package, including $1.14 million base salary
FLUT•
Spice maker McCormick's Q3 sales, adjusted profit beat expectations
MKC•
Vicor jumps after Q3 growth forecast raise
VICR•
Gold steadies as cooler US inflation data counters higher Treasury yields
GLD•
Brookfield says Oaktree asset-backed finance fund closes with $2 billion in commitments
BAM•